Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-11
1991-11-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514287, 546 64, 546 67, A61K 3148, A61K 31415, C07D45702
Patent
active
050632345
ABSTRACT:
A method of inhibiting bone demineralization comprising administration of an effective amount of a compound having the formula ##STR1## where X is CH or N;
REFERENCES:
patent: 4166182 (1979-08-01), Kornfeld et al.
patent: 4201881 (1980-05-01), DeLuca et al.
patent: 4202979 (1980-05-01), Kornfeld et al.
patent: 4448721 (1984-05-01), DeLuca et al.
patent: 4468401 (1974-08-01), Hahn
patent: 4675322 (1987-06-01), Laguzza
"Osteoporosis", vol. 5, No. 3, National Institutes of Health Consensus Development Statement.
Raisz, L., Journal of the American Geriatrics Society, 30, 127-138 (1982).
Krieger et al., Calcif Tissue Int., 34, 239-244 (1982).
Schwartz et al., Clin. Orthop., No. 192, 180-184 (1985).
Kalu et al., Endocrinology, 122, 1847-1854 (1988).
Bryant Henry U.
Clemens James A.
Clardy S. Mark
Demeter John C.
Eli Lilly and Company
Raymond Richard L.
Whitaker Leroy
LandOfFree
Method of inhibiting demineralization of bone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting demineralization of bone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting demineralization of bone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-499552